Gentherm Wins 2024 Automotive News PACE Innovation Partnership Award
April 30, 2024 08:00 ET
|
Gentherm Inc
NORTHVILLE, Mich., April 30, 2024 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive...
Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)
April 30, 2024 08:00 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that all patients have been enrolled across the Phase 3 Orbit and Cosmic studies...
CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) Buyout and Encourages Investors to Contact the Firm
April 30, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, April 30, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) (“Cerevel”) on behalf of the company’s...
Auddia Announces Strategic Product Expansion With Cloud Based Artificial Intelligence and Natural Language Processing Offering
April 30, 2024 08:00 ET
|
Auddia Inc.
Proprietary AI and NLP Technology Used for Audio Stream Processing and Content Detection Being Ported to the Cloud Cloud Infrastructure Brings Scale Required to Attract and Enable SaaS Partnerships...
Ackroo Announces 2023 Audited Financial Results
April 30, 2024 08:00 ET
|
Ackroo Inc.
HAMILTON, Ontario, April 30, 2024 (GLOBE NEWSWIRE) -- Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company”), a gift card, loyalty marketing, payments and point-of-sale technology consolidator and...
Shape Therapeutics to Showcase RNA Editing in the Brain and Validation of their Stable AAV Producer Cell Line at ASGCT 2024
April 30, 2024 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader at the convergence of AI and RNA editing to revolutionize genomic medicine, today announced its upcoming oral presentations...
Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
April 30, 2024 08:00 ET
|
Biora Therapeutics, Inc.
Dosing of all patients in the trial has been successfully completed; final results are expected to be available in late Q2 2024.
Banco Santander-Chile Announces First Quarter 2024 Earnings
April 30, 2024 08:00 ET
|
Banco Santander Chile
SANTIAGO, Chile, April 30, 2024 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its results1 for the three-month period ended March 31, 2024, and first...
In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy
April 30, 2024 08:00 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies...
Stytch Introduces Major Updates to its B2B Authentication Product
April 30, 2024 08:00 ET
|
Stytch
SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Stytch, the most powerful identity platform built for developers, today announced major updates to its B2B authentication product, purpose-built for...
- May 07, 2024 20:42 ET NANO Nuclear Energy Announces Pricing of Initial Public Offering
- May 07, 2024 19:32 ET Mercuriades 2024: Crakmedia Takes Top Honours in Productivity Enhancement